Money Talks: Profits Before Patient Safety comes as filmmaker Kathleen Slattery-Moschkau’s second film about the issues within the pharmaceutical industry. Her debut film Side Effects, was a fictional approach to exposing the issues, based on her decade working as a drug sales rep for two of the nation’s top pharmaceutical companies. Because of the overwhelming response from people all over the world, Slattery-Moschkau felt there was a need to leave Hollywood behind, and present a more informational, academic approach to the topic.
“Side Effects generated such an outstanding dialogue on the issues of drug promotion and ethics that we felt compelled to go to the experts,” said Slattery-Moschkau. “Money Talks is the straight-shooting answer to a lot of the questions that consumers need to know.”
In Money Talks, Alex Sugarman-Brozan, JD, of Prescription Access Litigation shares sweeping statistics about the pharmaceutical industry’s marketing force. He cites that there are over 80,000 pharmaceutical sales reps employed in the U.S. alone, or one for every four doctors.
Dr. John Abramson, author of Overdo$ed America, explains how the pharmaceutical companies are taking us away from evidence-based medicine. He shares eye-opening information about how the Federal Drug Administration and New England Journal of Medicine, as well as other respected organizations, are no longer trusted sources for unbiased information on prescription drugs.
Other featured interviews include Dr. Bob Goodman of Columbia University who founded the program No Free Lunch, and Dr. Jerome Hoffman of UCLA Medical School.